市场调查报告书
商品编码
1399613
临床试验影像市场规模 - 按服务(临床试验设计和咨询服务)、影像技术、治疗领域、最终用户、2023-2032 年全球预测Clinical Trial Imaging Market Size - By Service (Clinical Trial Design & Consultation Services), Imaging Technique, Therapeutic Area, End-user, Global Forecast 2023-2032 |
在全球生物製药产业不断扩张的推动下,临床试验影像市场规模预计从 2023 年到 2032 年将以 7.9% 的CAGR成长。从事新疗法开发的生物製药公司越来越依赖先进的影像服务来评估药物的疗效和安全性。随着生物製药公司对精准医疗和标靶治疗的日益关注,临床试验中对强大且专业的影像解决方案的需求不断增加。
此外,主要参与者正在投资尖端解决方案,包括用于影像解释的人工智慧应用程序,以满足对精确和即时资料日益增长的需求,同时吸引寻求最先进成像服务的赞助商和研究人员,进一步加速产业扩张。例如,2023 年 3 月,Clario 推出了一款基于云端的影像检视器应用程序,供申办者和合约研究组织 (CRO) 检查临床试验影像。
整个产业分为服务、影像技术、治疗领域、最终用户和地区。
从服务来看,临床试验设计和咨询服务市场在 2022 年获得了巨大的吸引力,预计 2023 年至 2032 年期间将实现 8.7% 的成长率。临床试验设计和咨询服务见证了对规划成像方案的高需求,以确保法规遵循和优化试验效率。随着製药和生物技术公司越来越认识到成像终点在临床试验中的重要性,对专业设计和咨询服务的需求也不断增长。
就最终用户而言,医疗器材製造商领域的临床试验影像市场预计从 2023 年到 2032 年将以 7.3% 的CAGR成长。医疗器材製造商越来越多地将影像技术纳入临床试验,以评估产品的功效和安全性。此外,医疗设备製造商和临床试验影像服务提供者之间持续合作,在遵守法规的同时促进精确的资料收集和分析,将有助于该细分市场的成长。
从地区来看,由于临床研究活动的增加和对医疗保健创新的日益重视,亚太地区临床试验影像产业预计在 2023 年至 2032 年间呈现 8.8% 的CAGR。该地区患者群体多样化以及具有成本效益的临床试验解决方案的可用性更高,正在吸引跨国製药公司的投资。一些市场参与者也采取措施,帮助公共医疗机构成为卓越的临床研究中心,以提升价值链,扩大区域产业前景。例如,2023年10月,罗氏製药印度公司在印度启动了卓越临床试验计划,帮助印度公共卫生机构进行临床试验和药物研究。
Clinical Trial Imaging Market size is projected to expand at 7.9% CAGR from 2023-2032 driven by the expanding biopharmaceutical sector across the globe. Biopharmaceutical companies, engaged in the development of novel therapies, increasingly rely on advanced imaging services to assess drug efficacy and safety. With the growing focus of the biopharma companies on precision medicine and targeted therapies, the demand for robust and specialized imaging solutions in clinical trials is rising.
Furthermore, key players are investing in cutting-edge solutions, including AI applications for image interpretation for catering to the increasing demand for precise and real-time data, whilst attracting sponsors and researchers seeking state-of-the-art imaging services, further accelerating the industry expansion. For instance, in March 2023, Clario launched a cloud-based Image Viewer application for sponsors and contract research organizations (CROs) to examine clinical trial images.
The overall industry is segmented into service, imaging technique, therapeutic area, end user, and region.
As per service, the clinical trial design & consultation services market gained significant traction in 2022 and is anticipated to depict 8.7% growth rate during 2023-2032. Clinical trial design and consultation services are witnessing high demand for planning imaging protocols for ensuring regulatory compliance and optimizing trial efficiency. With pharmaceutical and biotechnology companies increasingly recognizing the importance of imaging endpoints in clinical trials, the demand for specialized design and consultation services is also rising.
In terms of end-user, the clinical trial imaging market from the medical devices manufacturers segment is estimated to expand at 7.3% CAGR from 2023 to 2032. Medical device manufacturers are increasingly incorporating imaging technologies in clinical trials to assess product efficacy and safety. Additionally, the ongoing collaboration between medical device manufacturers and clinical trial imaging service providers for facilitating precise data acquisition and analysis while complying with regulations will contribute to the segment growth.
Regionally, the Asia Pacific clinical trial imaging industry is set to exhibit 8.8% CAGR between 2023 and 2032 attributed to the increasing clinical research activities and the growing emphasis on healthcare innovation. The presence of diverse patient population and the higher availability of cost-effective clinical trial solutions in the region are attracting investments from multinational pharmaceutical companies. Several market participants are also taking steps to help public healthcare facilities become clinical research centers of excellence for ascending the value chain, augmenting the regional industry outlook. For instance, in October 2023, Roche Pharma India commenced its clinical trial excellence initiative in India to help public health institutions in the nation conduct clinical trials and drug research.